Healthcare Triangle Company Top Insiders
| HCTI Stock | USD 2.75 -0.09 -3.17% |
Healthcare Triangle employs about 59 people. The company is managed by 17 executives with a total tenure of roughly 138 years, averaging almost 8.0 years of service per executive, having 3.47 employees per reported executive. A leadership review of Healthcare Triangle matters because management quality often shapes how effectively strategy is translated into revenue growth, margins, and cash generation. The practical question is whether leadership is creating repeatable business progress instead of simply managing the narrative around the company.
Healthcare | Build portfolio with Healthcare Stock |
Management Team Effectiveness
The company has return on total asset (ROA) of -26.85 % meaning that the return on assets was negative, reflecting a $26.85 loss per $100. This sits far below comparable companies. Similarly, it shows a return on stockholder's equity (ROE) of -118.48 %, suggesting that it is drawing down equity without generating offsetting profit.Per market data dated March 20, 2026, Common Stock Shares Outstanding is projected to contract toward approximately 16.4 K. In addition to that, Net Loss is projected to contract toward approximately -7.2 M.
Stock Institutional Investors
Institutions hold about 3.09% of shares while insiders own roughly 8.14%. Annual revenue is about 11.7 Million. How the institutional base reacts to earnings changes can move Healthcare Triangle in the short term. Shares outstanding are near 5.9 M. Whether the institutional base is growing or shrinking quarter over quarter matters more than the current snapshot.
| Shares | Tower Research Capital Llc | 2025-09-30 | 0.0 | Brookstone Capital Management Llc | 2025-09-30 | 0.0 | Ewa, Llc | 2025-09-30 | 0.0 | Millennium Management Llc | 2025-09-30 | 0.0 | Two Sigma Investments Llc | 2025-09-30 | 0.0 | Sbi Securities Co Ltd | 2025-09-30 | 0.0 | 3chopt Investment Partners, Llc | 2025-09-30 | 0.0 | Vanguard Group Inc | 2025-12-31 | 80.4 K | Geode Capital Management, Llc | 2025-12-31 | 53.8 K | State Street Corp | 2025-09-30 | 28.7 K | Ubs Group Ag | 2025-09-30 | 13.7 K |
Insider Trading Activities
Insider activity around Healthcare Triangle matters because officers and directors often act on business changes before the market catches up. Current market capitalization is about 12.8 Million. These records work best as context, not as standalone buy-or-sell signals.
Outstanding Bonds
Outstanding bonds linked to Healthcare Triangle can tell investors a great deal about how the company finances itself beyond common equity markets. Maturity profile, refinancing windows, and coupon burden can all affect how resilient the capital structure looks in a weaker market.
| HEALTHCARE TRUST OF Corp BondUS42225UAH77 | View | |
| US42225UAG94 Corp BondUS42225UAG94 | View | |
| HR 3625 15 JAN 28 Corp BondUS42225UAK07 | View | |
| HR 205 15 MAR 31 Corp BondUS42225UAM62 | View | |
| HR 24 15 MAR 30 Corp BondUS42225UAL89 | View | |
| HEALTHCARE TR AMER Corp BondUS42225UAD63 | View | |
| HEALTHCARE TR AMER Corp BondUS42225UAF12 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Shares in Circulation | First Issued 2015-12-31 | Previous Quarter 21.2 K | Current Value 21.2 K | Average Shares Outstanding 16.2 K | Quarterly Volatility 3.4 K |
Macro event markers
Holders Distribution
Institutional investors in Healthcare Triangle typically operate with more research capacity, technology, and trading scale than retail holders, which is why their activity can materially affect price behavior. One practical risk is that institutions can own millions of shares, so concentrated selling can pressure the stock quickly once sentiment changes.
Market Cap and Value
Workforce Comparison
Healthcare Triangle places third for number of employees among direct rivals. The total workforce of Health Care industry is currently estimated at about 499. Healthcare Triangle retains roughly 59.0 in number of employees claiming about 12% of equities under Health Care sector.
Profit Margins
The company has Profit Margin (PM) of -48.0 %, which suggests pricing discipline or cost control requires further improvement. This sits far below comparable companies. Similarly, it shows Operating Margin (OM) of -38.0 %, which implies that the company is operating at a deficit of $38.0 per $100 of sales.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.28 | 0.2471 |
|
|
Insider Trading History
The insider timeline for Healthcare Triangle shows how management behavior has tracked against the stock's price over time. Shares outstanding are near 5.9 M. Since insider trades are publicly filed, the record helps verify whether management actions match their words.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2025-03-01 | 3.0 | 3 | 1 | 352,936 | 2,550,000 |
| 2023-03-01 | 0.25 | 1 | 4 | 1.00 | 150,000 |
| 2021-09-01 | 3.0 | 3 | 1 | 762,000 | 250,000 |
Notable Stakeholders
Reviewing the stakeholders around Healthcare Triangle can help investors understand which people or institutions may influence direction, governance, and strategic pressure. This becomes more informative when investors want to understand not just ownership, but influence, incentives, and strategic pressure points.
| Lakshmanan Kannappan | Head CoFounder | Profile | |
| Chris Paalman | Director Operations | Profile | |
| Shelly Pierce | Director Acquisition | Profile | |
| Shibu Kizhakevilayil | Head Director | Profile | |
| Suresh Venkatachari | Pres Chairman | Profile | |
| Sudish Mogli | Consultant | Profile | |
| Abhay Borwankar | Vice Technology | Profile | |
| David Ayanoglou | Chief Officer | Profile | |
| Ceasar Cifuentes | Senior Sales | Profile | |
| Sujatha Ramesh | Chief Officer | Profile | |
| Anand Kumar | Interim Officer | Profile | |
| Damian David | Senior Development | Profile | |
| Kristi Lane | VP Management | Profile | |
| Thyagarajan Ramachandran | Chief Officer | Profile | |
| Michael Campana | Vice Marketing | Profile | |
| Lisna Ismail | Communications Marketing | Profile | |
| Michael Gill | VP Fin | Profile |
Management Information & Data Sources
Healthcare Triangle is a micro-cap company in Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care. Executive review focuses on insiders, senior management, and employee signals. Management quality is often reflected indirectly through margin durability, reinvestment choices, and governance signals. Healthcare Triangle employs 59 people.
Unless otherwise specified, data for Healthcare Triangle is compiled from periodic company reporting and market reference feeds and standardized for comparability. Updates may occur throughout the day. Insider and management fields are mapped from published filings and company disclosures.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardWorkforce Efficiency and Productivity
Workforce efficiency at Healthcare Triangle can help investors judge how effectively labor resources are being converted into revenue and profit over time. The business is commonly classified in the Healthcare sector and the Health Information Services industry.
Healthcare Triangle Manpower Efficiency
Return on Healthcare Triangle Manpower
| Revenue Per Employee | 198.2K | |
| Revenue Per Executive | 688K | |
| Net Loss Per Employee | 101.2K | |
| Net Loss Per Executive | 351.1K |
Popular Tools for Healthcare Stock analysis
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |